Skip to content
Review Open access

Microbial cues and T cell immunity: deciphering their interactions in chronic liver disease

Oct 2026 · Experimental and Molecular Medicine · Vol 58, pp. 3312 - 3325 · 0 citations · 212 references
Medicine

Abstract

Chronic liver disease (CLD) poses a major global health challenge, as its progression to cirrhosis and hepatocellular carcinoma significantly contributes to worldwide morbidity and mortality. Mounting evidence has identified the gut microbiota as a critical modulator of CLD progression, primarily via the gut–liver axis. The liver is continuously exposed to gut-derived signals through the portal circulation, while reciprocally secreting bioactive mediators that shape intestinal microbial composition and function. This bidirectional network enables intricate crosstalk between the gut microbiota and the host immune system. In particular, T lymphocytes, the central effectors of adaptive immunity, are tightly regulated by gut microbiota and their metabolites. Conversely, T cells also modulate the gut microbial ecosystem. Herein, we summarize current knowledge on this bidirectional crosstalk, focusing on how gut microbiota shape T cell differentiation, function and plasticity, as well as the reciprocal impact of T cells on the gut microbiota. Furthermore, we evaluate how these interactions influence the development and progression of various CLDs, including autoimmune liver diseases, alcohol-associated liver disease, metabolic dysfunction-associated steatotic liver disease and viral hepatitis. Finally, we discuss the therapeutic potential of targeting gut microbiota–T cell interactions through immunomodulatory and microbiota-directed strategies to offer novel therapeutic approaches. Chronic liver disease (CLD) is a significant global health issue, causing millions of deaths annually, with limited therapeutic options. Recent research highlights the role of the gut microbiota in CLD pathogenesis, focusing on the gut–liver axis, where microbial products and immune responses, particularly T cells, influence liver health. This review explores how gut microbiota modulates T cell responses in CLD, including autoimmune liver diseases, alcohol-associated liver disease, metabolic dysfunction-associated steatotic liver disease and viral hepatitis. The authors discuss the interactions between gut microbiota and T cells, emphasizing the potential for novel therapeutic strategies targeting these interactions. Key findings include the modulation of T cell subsets by microbial metabolites, which can influence disease progression and immune responses. The review suggests that understanding these interactions could lead to innovative treatments for CLD. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.